加载中........
×

Speakers

2009-3-26 我要评论0
Tags:

 Speakers

--------------------------------------------------------------------------------
 

Dr. Abdulrazak Abyad, Director, Abyad Medical Center and Middle-East Longevity Institute, Lebanon

Dr. Ajay K. Banga, Professor and Chair, Mercer University, USA

Dr. Alan C Rigby, Director, Harvard Medical School, USA

Dr. Alex Kiselyov, President, deCODE Chemistry, USA

Dr. Alex Odermatt, Professor, University of Basel, Switzerland

Dr. Amir Pelleg, President and CSO, Cordex Pharma, Inc., USA

Dr. Amos PANET, Professor, THE HEBREW UNIVERSITY OF JERUSALEM, Israel

Dr. Andrei Thomas-Tikhonenko, Chair, Cancer Biology Graduate Program, University of Pennsylvania, USA

Dr. Andrew C. Chang, Executive Director, PharmaNet Consulting, Pharmanet Development Group, Inc., USA

Dr. Aristidis Tsatsakis, President, University of Crete, Greece

Dr. Asad Ullah Khan, Associate Professor, Interdisciplinary Biotechnology Unit, Aligarh M University, India

Dr. Athina Geronikaki, Professor, Aristotelian University of Thessaloniki, Greece

Dr. Avram Hershko, Professor of Biochemistry, Technion - Israel Institute of Technology Rappaport Institute, Israel

Dr. B. S. Kasinath, Professor, University of Texas Health Science Center, USA

Dr. Bal L. Lokeshwar, Co-Director, Division of Urology Research, University of Miami School of Medicine, USA

Dr. Bal Lokeshwar, Associate Professor and Director of Gastroenterology Research, University of Oklahoma Health Sciences Center, USA

Dr. Bjorn Mellgord, Director Scientific Affairs, AstraZeneca, USA

Dr. Bolin Geng, Principal Scientist, Infection Discovery, AstraZeneca R&D, USA

Dr. Brian A Hemmings, Senior Scientist, Friedrich Miescher Institute for Biomedical Research, Switzerland

Dr. Brian A Whittle, Managing Director, Kings College London, Department of Pharmacy, UK

Dr. Brian Bronk, Senior Director, Pfizer, USA

Dr. Brian Meltzer, Senior Director, Venture Program Management, Johnson & Johnson Corporate Development, USA

Dr. Bruce Morimoto, Vice President, Allon Therapeutics Inc., USA

Dr. Carmela Abraham, Professor, Boston University School of Medicine, USA

Dr. Catherine Huang, Project Scientist, Reseach and Development, SeraCare Life Sciences, USA

Dr. Chaohong Sun, Research Investigator, Protein NMR Research, Abbott Laboratories, USA

Dr. Charles A. Dinarello, Professor, University of Colorado Health Sciences Center, USA

Dr. Charles H. Reynolds, Research Fellow, Computer-Aided Drug Discovery, Johnson & Johnson Pharma R&D, USA

Dr. Charlie Johannes, Director, Chemistry Forma Therapeutics, Inc., Singapore

Dr. Chengbin Wu, Associate Research Fellow, Abbott, USA

Dr. Choung U. Kim, Vice President, Chemistry, Gilead Sciences Benzothiadiazine Hepatitis C NS5B, USA

Dr. Chris Senanayake, Vice President, Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., USA

Dr. Christian K Schneider, Head, Division EU-Cooperation/Microbiology, Paul-Ehrlich-Institute, Germany

Dr. Christopher Bianca, Professor of Chemistry, Clinical Consultant, Keystone College Academia, USA

Dr. Christopher O'Donnell, Director, Global Research & Development, Pfizer, USA

Dr. Christopher Yochim, Associate Director, External Relations, Strategic Planning & Business Development, AstraZeneca, UK

Dr. Chuang Lu, Associate Director, DMPK, Drug Safety and Disposition Millennium, The Takeda Oncology Company, USA

Dr. Claudio D. Denoya, Research Fellow - Group Leader, Pfizer Global R&D, USA

Dr. Clovis O. Da Fonseca, Associate Professor of Neurosurgery, Universidade Federal Fluminense, Brazil

Dr. D Bonnet, Senior Group Leader, London Research Institute, Haematopoietic Stem Cell Laboratory, UK

Dr. Damas Molero Sanchez, General Manager, 3 P Biopharmaceuticals, USA

Dr. Damian Lismore, CFO, Biota Holdings Limited, USA

Dr. Danhua Chen, Senior Principal Scientist, Pfizer Inc., USA

Dr. Danping Li, Director of Formulation Development, Rib-X Pharmaceuticals, USA

Dr. Darren Hodgson, Advisor, Clinical Biomarker Group, AstraZeneca, UK

Dr. Darren Hodgson, Biomics Advisor, AstraZeneca, UK

Dr. Darwin J. Prockop, Director, TInstitute for Regenerative Medicine, Scott & White, USA

Dr. David A. Winkler, Professor, CSIRO Molecular and Health Technologies, Australia

Dr. David Craik, Professor, Institute for Molecular Bioscience, The University of Queensland, Australia

Dr. David Rhodes, Head of Discovery, Avexa Ltd, Australia

Dr. Desire Collen, CEO, ThromboGenics, USA

Dr. Dhanya Menon, Marketing Portfolio Manager, Ocimum Biosolutions, India

Dr. Domenico Mastrangelo, Senior Scientist, Department of Ophthalmology, University of Siena, Italy

Dr. Domenico Pratico, Associate Professor, Pharmacology Temple University, USA

Dr. Dora M. Schnur, Principal Scientist, Bristol-Myers Squibb Company, USA

Dr. Douglas Macdonald, Director, Drug Discovery CHDI Management / CHDI Foundation, California

Dr. Dusica Maysinger, Associate Professor, Department of Pharmacology and Therapeutics, McGill University, Canada

Dr. Duu-Gong Wu, Executive Director, Consulting Division, PharmaNet, Inc., USA

Dr. Ekambar Kandimalla, Vice President, Discovery, Idera Pharmaceuticals, USA

Dr. Elena Vigorito, Group Leader, The Babraham Institute, UK

Dr. Emanuel F. Petricoin,Co-Director, Ctr. for Applied Proteomics and Molecular Medicine, USA

Dr. Erik Hessen, President of the Norwegian Neuropsychological Association, Akershus University Hospital, Norway

Dr. Esam Z. Dajani, President, IDDC Corporation, USA

Dr. Fabio Garofolo, Vice-president, Algorithme Pharma Inc., Canada

Dr. Frank Bretz, Director, Novartis Pharma AG, USA

Dr. Frank Zhang, CEO, genscript, USA

Dr. Galila Agam, Associate Professor, Ben-Gurion University of the Negev, Israel

Dr. Gary Wormser, Professor, New York Medical College, USA

Dr. George Lin, Chief Medical Officer, Biological Mimetics, Inc., USA

Dr. George Schlich, in-house counsel, Schlich & Co, UK

Dr. Girish KOTWAL, Professor, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, USA

Dr. Giulio M. Pasinetti, Professor, Departments of Psychiatry and Geriatrics and Adult Development, USA

Dr. Gloria Cristalli, Professor, Dean of the Pharmacy Faculty of the University of Camerino, Italy

Dr. Graeme Robertson, Vice President of Therapeutic Research, Siena Biotech S.p.A. A company, USA

Dr. Gregory Stahl, Professor, Harvard Medical School, USA

Dr. Guru Sonpavde, Clinical Assistant professor, US Oncology Research, Inc., USA

Dr. Gus Rosania, Associate Professor, University of Michigan, USA

Dr. Hai Wei, Associate Professor, Shanghai Unviversity of Traditional Chinese Medicine, China

Dr. Haiching Ma, Chief Technology Officer, Reaction Biology Corporation, USA

Dr. Hemant Sarin, Research Fellow, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, USA

Dr. Hengjun Gao, Vice President, Shanghai Biochip Co., Ltd, China

Dr. Hengmiao Cheng, Associate Research Fellow, Pfizer La Jolla Labs, USA

Dr. Hequn Yin, principle scientist, Shanghai R&D Center, Novartis, China

Dr. Heribert Stoibe, Professor, Innsbruck Medical University, Austria

Dr. Herman Waldmann, Cofounder, Chairman, Scientific Advisory Board Tolerx, USA

Dr. Hitoshi Matsushime, Director, Astellas Pharmaceutical Inc., Japan

Dr. Hong Wan, Principal Scientist, AstraZeneca R&D Molndal, Sweden

Dr. Horst P. Schmitt, Professor, Institute of Pathology, Department of Neuropathology, University of Heidelberg, Germany

Dr. Hua Gao, Associate Research Follow, Computational Chemistry, Pfizer, USA

Dr. Huaiyu Mi, Senior Biologist, SRI International, USA

Dr. Huifen Faye Wang, Director, PDM Bioanalytical Research Biotherapeutics, Pfizer, USA

Dr. Ian A Cliffe, Director - Head Medicinal Chemistry, Drug Discovery Research, Ranbaxy Laboratories Limited, India

Dr. Ian Gourley, Senior Director, Wyeth Research, USA

Dr. Igor Sherman, CEO, Alpha Cancer Technologies Inc., USA

Dr. Iman El-Hariry, Group Director, Oncology MDC, Europe GlaxoSmithKline R&D, UK

Dr. Isaiah (Shy) Arkin, Professor, The Hebrew University, Israel

Dr. J. Fred Pritchard, Vice President, Drug Development, Development and Regulatory Services, MDS Pharma Services, USA

Dr. James C. Lee, Professor, University of Texas Medical, USA

Dr. Jane Papadaki-Markley, Sales and Marketing Director for North America, DxS Ltd, USA

Dr. Jan-oke Gustafsson, Professor & Chairman, Dept. of Biosciences & Nutrition, Karolinska Institutet, Sweden

Dr. Jared Rutter, Assistant Professor, University of Utah School of Medicine, USA

Dr. Jason (Gang) Jin, Co-Founder and Executive Vice President of Global Business (CRO) of Shanghai Biochip Co., Ltd, China

Dr. Jason K. Kim, Director, Pennsylvania State University College of Medicine, USA

Dr. Jason K. Kim, Professor of Molecular Medicine, University of Massachusetts Medical School, USA

Dr. Jeffrey S. Albert, Principal Scientist, CNS Discovery Research, AstraZeneca Pharmaceuticals, USA

Dr. Jian Kuang, Associate Professor, MD Anderson Cancer Center, The University of Texas, USA

Dr. Jianling Wang, Head, ADME Profiling Cambridge, Novartis Institutes for Biomedical Research, USA

Dr. Jin Li, Co-founder and the Chief Operating Officer, Shenogen Pharma Group, China

Dr. Jingping Mo, Senior Director, Pfizer, USA

Dr. Jingsong Wang, Director, Discovery Medicine & Clinical Pharmacology, Bristol-Myers Squibbs, USA

Dr. Jinhe Li, Research Investigator, Abbott, USA

Dr. Jinhua Zhang, Senior Scientist, Simulations Plus, Inc., USA

Dr. Johan Weigelt, Associate Director/Chief Scientist, Structural Genomics Consortium Karolinska Institutet, Sweden

Dr. Johannes Oldenburg, Professor, Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany

Dr. John A. Cidlowski, Principal Investigator, Molecular Endocrinology Group, NIH, USA

Dr. John D. Baxter, Professor, Diabetes Center and Department of Medicine, University of California-San Francisco, USA

Dr. John F. Thompson, Professor, Royal Prince Alfred Hospital, The University of Sydney, Australia

Dr. John R. Cashman, Director and Founder, Human BioMolecular Re-. search Institute, USA

Dr. Jorg Vollmer, Managing Director, Coley Pharmaceutical GmbH, Germany

Dr. Jos Jonkers, Group leader, Netherlands Cancer Institute, The Netherlands

Dr. José Duca, Senior Principal Scientist, 3D - Drug Design Department, Schering Plough Research Institute, USA

Dr. Joseph K.-K. Li, Professor, Department of Biology, Utah State University, USA

Dr. Josy Breuer, Senior Director, Bayer Schering Pharma AG, Germany

Dr. Jun Shi Senior, Director, Daiichi Sankyo Pharma Development, Japan

Dr. Jurgen Moll, Director, Cell Biology Dep, Nerviano Medical Sciences, Italy

Dr. Jurgen Wagner, Unit Head, Neuroscience, Novartis Institutes, Switzerland

Dr. Kailash Swarna, Executive Director, Research & Development, Amgen, Inc., USA

Dr. Kailash Swarna, Executive Director, Research & Development, Amgen, Inc, USA

Dr. Kamaleshwar Prasad Singh, Lead Scientist, Genomic & Proteomic Facility, Texas Southern University, USA

Dr. Karsten Kristiansen, Professor, University of Southern Denmark, Denmark

Dr. Kaushik Mitra, Senior Research Chemist, Department of Drug Metabolism, Merck Research, USA

Dr. Keith D. Kaufman, Executive Director Clinical Research – Metabolism, Merck and Co., Inc., USA

Dr. Keizo Koya, Senior Vice President, Drug Development, Synta Pharmaceuticals Corp, USA

Dr. King Lee, VP Regulatory/Clinical Affairs, Cornerstone Pharmaceuticals, USA

Dr. L. Van Gaal, Professor, Dept. Endocrinology and Diabetology Antwerp University Hospital, Belgium

Dr. Lawrence L. Gan, Director, Biogen Idec, Inc., USA

Dr. Liang Cheng, Professor, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, USA

Dr. Liang Tang, Principal Research Scientist, Bayer HealthCare, USA

Dr. Lijun Sun, VP, Chemistry Synta Pharmaceuticals Corp, USA

Dr. Lingyun Chengk, Director of Ocular PharmacologykJacobs Retina Center/Shiley Eye Center, University of California, USA

Dr. Luigi Aurisicchio, Research Fellow, Group Leader, Merck & Co., Italy

Dr. Lutz Jermutus, Director of Research-Technology, Medimmune, UK

Dr. Mahboob Rahman, Senior Director, Centocor/Johnson & Johnson, USA

Dr. Makoto Ohori, Senior Researcher, Astellas Pharma Inc, Japan

Dr. Mandip Singh Sachdeva, Professor, Florida A&M University, USA

Dr. Manu V. Chakravarthy, Associate Director, Experimental Medicine, MERCK, USA

Dr. Manu V. Chakravarthy, Associate Director, Merck, USA

Dr. Manuel Buttini, Principal Scientist, Elan Pharmaceuticals, USA

Dr. Manuel Carrondo, Professor, Instituto De Biologia Experimentale Tecnologica, Portugal

Dr. Marco Bregni, Chair, Solid Tumor Working Party, Italy

Dr. Maria José Sá, Senior Neurologist, Hospital S Hospital S Joao, Portugal

Dr. Maricarmen Planas-Silva, Assistant Professor, Department of Pharmacology, Penn State College of Medicine, USA

Dr. Mark E. Anderson, Professor, University of Minnesota, Stanford University, USA

Dr. Mark S. Shearman, Executive Director, Neuroscience Drug Discovery, Merck Research Laboratories Boston, USA

Dr. Mark Truesdale, Senior Product Manager, Genetix Ltd, UK

Dr. Marketa J Zvelebil, Team Leader, Cancer Informatics, The Institute of Cancer Research, UK

Dr. Markus Tobler, Director, Zeptosens – a Division of Bayer (Schweiz) AG, Switzerland

Dr. Marlene L. Cohen, Lilly Research Fellow (retired), Adjunct Professor of Pharmacology, Eli Lilly and Company;Indiana University School of Medicine, USA

Dr. Matthias von Herrath, Professor, Institute for Allergy and Immunology, University of California, USA

Dr. Mauricio Rojas, Assistant Professor, Division of Pulmonary, Emory University, USA

Dr. Melvyn Little, CSO, Affimed Therapeutics AG, Germany

Dr. Michael B. Bolger, Chief Scientist and Director, Simulations Plus, Inc., USA

Dr. Michael J. Shapiro, Associate Professor, University of Maryland, USA

Dr. Michael J. Waring, Professor, the Wine Committee, Jesus College, England

Dr. Michal Dubovicky, Deputy Director, Institute of Experimental Pharmacology, Slovak

Dr. Ming Wang, Scientific Director, Amgen, Inc., USA

Dr. Mirko Diksic, Director, Department of Neurology and Neurosurgery, McGill University, Canada

Dr. Mitchell Ho, Head, Antibody Therapy Unit, National Cancer Institute, NIH, USA

Dr. Mohammad Mikati, Chairman and Professor, American University of Beirut, USA

Dr. Naitee Ting, Director, Biostatistics, Pfizer Inc., USA

Dr. Neil Press, Group Leader, Novartis Institutes for Biomedical Research, UK

Dr. Niek Dekker, Associate Director, AstraZeneca, Swedish

Dr. Nirmala Bhogal, Scientific Director, Fund for the Replacement of Animals in Medical Experiments (FRAME), UK

Dr. Ole Vesterqvist, Director,Biomarker Lab & Outsourcing, Clinical Translational Medicine, Wyeth Research, USA

Dr. Ole Vesterqvist, Senior Director, Biomarker Lab & Outsourcing, Clinical Translational Medicine, Wyeth Research, USA

Dr. Oleg Targoni, Director, Laboratory Cellular Technology Ltd., USA

Dr. Olof Larsson, Associated Director, Department of Molecular, Astrazeneca R&D Sodertolje, Sweden

Dr. Omar L. Francone, Research Fellow, Pfizer Global Research and Development, USA

Dr. Origène Nyanguile, Principal Scientist, Johnson & Johnson Pharmaceutical, USA

Dr. Oscar Joseph Trask, Head of Cellular Imaging Technologies Neurobiology, Duke University, USA

Dr. Pardeep K. Gupta, Associate Prof., University of the Sciences in Philadelphia, USA

Dr. Parminder Kaur, Managing Director, RegPak BioPharma Consulting, The Netherlands

Dr. Patricio F. Reyes, Director, Barrow Neurological Institute, USA

Dr. Paul M. Vanhoutte, Head of the Department of Pharmacology, University of Hong Kong, China

Dr. Paul Shapiro, Associate Dean for Research and Graduate Studies, University of Maryland School of Pharmacy, USA

Dr. Peter Hoffmann, VP New Technology Development, Genzyme Pharmaceuticals, USA

Dr. Ping Li, Senior Fellow, Novartis Pharma AG, USA

Dr. Piotr H. Karpinski, Principal Fellow, Novartis Pharmaceuticals Corporation, USA

Dr. Pirouz Daftarian, Director, Biological Modifiers/Hybridoma Core, University of Miami, USA

Dr. Prasad Tata, Manager-Pharmacokinetics, Mallinckrodt, Inc., USA

Dr. R.J.M.M. Thoolen, Toxicologic Pathologist, Global Pathology Support, The Netherlands

Dr. Radium Bhattacharya, Director, Gujarat AIDS Awareness and Prevention Unit, India

Dr. Ric M. Procyshyn, Associate Clinical Professor, University of British Columbia, Canada

Dr. Richard Beger, Branch Chief, Center for Metabolomics, National Center for Toxicological Research, USA

Dr. Richard Jeppsson, Public Affairs & Communication Director, sanofi aventis, USA

Dr. Richard White, Manager Toxicology and Pharmacology, OphthalmoPharma, Switzerland

Dr. Rob Jones, Director, Medicinal Chemistry, Arena Pharmaceuticals, USA

Dr. Robert Becker, V.P, Business Development, Vaxinnate, USA

Dr. Robert Guttendorf, Vice President of Pharmacology and Experimental Therapeutics, Sequoia Pharmaceuticals Inc., USA

Dr. Roland E. Dolle, Senior Director, Department of Chemistry, Adolor Corporation, USA

Dr. Ronald Rooke, Director, Immunopharmacology Dept, Transgene, France

Dr. Rosario LoBrutto, Project Leader, Novartis Pharmaceuticals Corporation, USA

Dr. Rouzbeh R. Taghizadeh, CSO, AuxoCell Laboratories, Inc., USA

Dr. Rubina Heptulla, Assistant Professor, Baylor College of Medicine, USA

Dr. Ruojing Yang, Senior research biologist, Merck & Co. Inc, USA

Dr. Ryuichi Morishita, Professor, Department of Clinical Gene Therapy, Osaka University, Japan

Dr. Sabrina C. Desbordes, Differentiation and Cancer Program, CRG-Centre de Regulació Genòmica, Spain

Dr. Saileta Prabhu, Scientist, Genentech, USA

Dr. Salomon Z. Langer, Vice President, Alpha-2 Pharmaceutica AB, Israel

Dr. Santosh R. D'Mello, Professor, Molecular and Cell Biology, University of Texas at Dallas, USA

Dr. Serge Guzy, CEO, XOMA (US) LLC, USA

Dr. Shaoxian Sun, Senior Principle Scientist, Pfizer Inc., USA

Dr. Shawn X. Yin, Senior Research Investigator, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, USA

Dr. Sheila Annie Peters, Associate Principal Scientist, Discovery DMPK & Bioanalytical Chemistry, AstraZeneca R&D, Sweden

Dr. Sherry Shen, analytical scientist, Boehringer Ingelheim Pharmaceutical Inc., USA

Dr. Siavoush Dastmalchi, Associate Professor, Tabriz University of Medical Sciences, Iran

Dr. Sid Topiol, Associate Director, Computational Chemistry Department, Lundbeck Research, USA

Dr. Sohaib Khan, Director, NCI Training Program in Cancer, UC College of Medicine, USA

Dr. Stefan Otto Mueller, Head, early and explanatory Toxicology, Merck KGaA, Germany

Dr. Stephan Schurer, Assistant Professor, Department of Pharmacology, University of Miami, USA

Dr. Steve Wilton, Head, Molecular Genetic Therapy, University of Western Australia, Australia

Dr. Steven Bodovitz, Principal, BioPerspectives, USA

Dr. Steven Hayes, Director, BellBrook Labs, LLC, USA

Dr. Stuart Madden, Senior Vice President of Product Development Consulting and Non Clinical Services, ICON PLC, USA

Dr. Sudhakar D. Garad, Group Head-Formulation Group, Novartis Institutes for Biomedical, USA

Dr. Susan Pond, CEO, Johnson & Johnson Research Pty Limited, Australia

Dr. Sushma Rathaur, Professor, Department of Biochemistry, Faculty of Science, Banaras Hindu University, India

Dr. Tao Wang, Principal Scientist, Bristol-Myers Squibb R&D, USA

Dr. Tim Hammonds, Head of Biochemistry and HTS, Cancer Research Technology, UK

Dr. Tomi Sawyer, Chief Scientific Officer, AILERON Therapeutics, USA

Dr. Toshikazu Hirao, Professor, Department of Applied Chemistry, Osaka University, Japan

Dr. Umesh R. Desai, Professor of Medicinal Chemistry and Interim Director, Virginia Commonwealth University, USA

Dr. Varghese John, Director, Alzheimer抯 Drug Discovery Network, USA

Dr. Vijay Kumar, Professor, University of Pennsylvania, USA

Dr. Vishal K. Gupta, Director, Pharmaceutical R&D, Covidien, USA

Dr. Viswanath Devanarayan, Director, Exploratory Statistics Global Pharmaceutical R&D, Abbott Laboratories, USA

Dr. Wenlin Huang, Senior Research Fellow, Institute of Microbiology,Chinese Academy of Sciences, China

Dr. Will Spooren, Project Leader, Hoffmann-La Roche, Switzerland

Dr. William N Washburn, Senior Research Fellow, Bristol-Myers Squibb Pharmaceutical Research Institute, USA

Dr. Wolfgang K.-D. Brill, Principal Research Scientist, Nerviano Medical Sciences s.r.I.Italy

Dr. Xian-Ming Zeng, Senior Director, Global Respiratory R&D, TEVA Pharmaceuticals, USA

Dr. Xiaoyu Liu, VP, R&D, Zhejiang Hisun Pharmaceutical Co., Ltd, China

Dr. Yin Liang, Head, Diabetes Section,Johnson & Johnson Pharmaceutical Research & Development, L.L.C, USA

Dr. Yogeshvar Kalia, Assistant Professor, University of Geneva, Switzerland

Dr. Yong-Jin Wu, senior scientist, Bristol-Myers Squibb, USA

Dr. Yoshiya Oda, Director, Eisai Co., Ltd., Japan

Dr. Yunsheng Hsieh, Principal Scientist, Schering-Plough Research, USA

Dr. Yvon C. Chagnon, Associate Professor, Laval University, Canada

Dr. Zaher A. Radi, Associate Research Fellow-Toxicologic Pathologist, Pfizer Global Research & Development, USA


Dr. Zhiyang Zhao, Director of Preclinical, Amgen, USA 



小提示:78%用户已下载梅斯医学APP,更方便阅读和交流,请扫描二维码直接下载APP

只有APP中用户,且经认证才能发表评论!马上下载

web对话